Medical Properties Trust, Inc. logo

Medical Properties Trust, Inc.

MPT

NYSEReal EstateREIT - Healthcare Facilities

Regular session

$4.125

+$0.01 · +0.24%

Aug 24, 10:10 AM ET

MPT company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

100

Deep Value

Momentum

32

Weakening

Sentiment

44

Mixed

Risk resilience

57

Elevated Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Medical Properties Trust, Inc. functions as a self-managed real estate investment trust (REIT). The company specializes in the financing, acquisition, and construction of healthcare properties, all structured under net-lease agreements. Its extensive property holdings encompass a diverse array of medical establishments, such as rehabilitation centers, extended-stay acute care hospitals, outpatient surgical facilities, hospitals catering to women and children, community and regional general hospitals, medical office complexes, and various other specialized care sites. The trust was established in 2003 by its co-founders, Edward K. Aldag Jr., R. Steven Hamner, Emmett E. McLean, and William Gilliard McKenzie, with its principal offices situated in Birmingham, Alabama.

Industry
REIT - Healthcare Facilities
Sector
Real Estate
Headquarters
US
CEO
Edward K. Aldag Jr.
Listed since
Jul 7, 2005
Employees
121

Market position

Day range

Current $4.125

52-week range

Current $4.125

Open
$4.10
Previous close
$4.115
Volume
688.39K
0.11× average
Average volume
6.19M
Average daily volume
Market cap
2.47B USD
Beta
1.46
Market reference 1
50-day average
$4.5556
-9.45% below average
200-day average
$5.0038
-17.56% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
12.29B USD
P/E (TTM)
-78.57×
P/B (TTM)
0.55×
P/S (TTM)
2.42×
EV / EBITDA
22.51×
Earnings yield
-9.22%
Free cash flow yield
7.68%
Dividend yield
8.48%

Profitability & efficiency

Gross margin
82.48%
Operating margin
56.61%
Net margin
-2.96%
Return on equity
-6.01%
Return on assets
-1.85%
Return on invested capital
3.74%

Financial health

Debt / equity
2.16×
Current ratio
1.51×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends131%-4%-140%-276%Gross margin, FY2021: 97.47%Gross margin, FY2022: 97.04%Gross margin, FY2023: 95.23%Gross margin, FY2024: 97.26%Gross margin, FY2025: 96.25%Operating margin, FY2021: 67.24%Operating margin, FY2022: 65.05%Operating margin, FY2023: 9.32%Operating margin, FY2024: 38.86%Operating margin, FY2025: 55.53%Net margin, FY2021: 42.47%Net margin, FY2022: 58.50%Net margin, FY2023: -63.83%Net margin, FY2024: -242.11%Net margin, FY2025: -28.50%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 97.47%. Gross margin FY2022 97.04%. Gross margin FY2023 95.23%. Gross margin FY2024 97.26%. Gross margin FY2025 96.25%. Operating margin FY2021 67.24%. Operating margin FY2022 65.05%. Operating margin FY2023 9.32%. Operating margin FY2024 38.86%. Operating margin FY2025 55.53%. Net margin FY2021 42.47%. Net margin FY2022 58.50%. Net margin FY2023 -63.83%. Net margin FY2024 -242.11%. Net margin FY2025 -28.50%.

Income trends

Revenue

972.02M USD-2.36%

Operating income

539.78M USD+39.53%

Net income

−277.05M USD+88.51%
Income trends across reported periods1.94B USD358.19M USD−1.22B USD−2.81B USDRevenue, FY2021: 1.54B USDRevenue, FY2022: 1.54B USDRevenue, FY2023: 871.8M USDRevenue, FY2024: 995.55M USDRevenue, FY2025: 972.02M USDOperating income, FY2021: 1.04B USDOperating income, FY2022: 1B USDOperating income, FY2023: 81.28M USDOperating income, FY2024: 386.85M USDOperating income, FY2025: 539.78M USDNet income, FY2021: 656.02M USDNet income, FY2022: 902.6M USDNet income, FY2023: −556.48M USDNet income, FY2024: −2.41B USDNet income, FY2025: −277.05M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 1.54B USD. Revenue FY2022 1.54B USD. Revenue FY2023 871.8M USD. Revenue FY2024 995.55M USD. Revenue FY2025 972.02M USD. Operating income FY2021 1.04B USD. Operating income FY2022 1B USD. Operating income FY2023 81.28M USD. Operating income FY2024 386.85M USD. Operating income FY2025 539.78M USD. Net income FY2021 656.02M USD. Net income FY2022 902.6M USD. Net income FY2023 −556.48M USD. Net income FY2024 −2.41B USD. Net income FY2025 −277.05M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue972.02M USD995.55M USD871.8M USD1.54B USD1.54B USD
Cost of goods sold36.42M USD27.26M USD41.57M USD45.7M USD39.1M USD
Gross profit935.61M USD968.29M USD830.23M USD1.5B USD1.51B USD
Selling, general, and administrative130.43M USD133.79M USD145.59M USD160.49M USD145.64M USD
Operating expenses395.83M USD581.45M USD748.95M USD493.47M USD466.89M USD
Interest income39.74M USD
Interest expense510.36M USD422.12M USD410.89M USD368.49M USD395.04M USD
Depreciation and amortization272.82M USD453.75M USD616.13M USD345.58M USD333.78M USD
Operating income539.78M USD386.85M USD81.28M USD1B USD1.04B USD
Net income−277.05M USD−2.41B USD−556.48M USD902.6M USD656.02M USD

Company facts updated Aug 24, 2026.

MPT peers

ETFs holding MPT

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research MPT

research.disclaimer